Having trouble finding Aimovig (Erenumab) at your pharmacy? Learn why this migraine prevention medication can be hard to find and what you can do about it in 2026.
You've finally found a migraine treatment that works. Your doctor prescribed Aimovig (Erenumab-aooe), and for the first time in years, you're having fewer migraine days. Then your pharmacy calls: they can't fill your prescription right now.
It's frustrating, stressful, and unfortunately more common than it should be. Aimovig isn't always easy to find — and there are specific reasons for that. In this article, we'll break down exactly why Aimovig can be hard to get your hands on, and more importantly, what you can do about it.
Aimovig is a prescription medication used for the preventive treatment of migraine in adults. It was the first FDA-approved drug in a class called CGRP receptor antagonists — medications that block the calcitonin gene-related peptide (CGRP) receptor, a key player in migraine attacks.
Aimovig is manufactured by Amgen and is given as a once-monthly subcutaneous injection using a prefilled SureClick autoinjector. It comes in two doses: 70 mg and 140 mg. Unlike older migraine preventives like Topiramate or Propranolol, Aimovig was designed specifically for migraine — and for many patients, it's been life-changing.
There are several reasons patients run into problems filling their Aimovig prescriptions. Here are the most common ones:
Aimovig is a biologic medication, which means it's produced from living cells rather than synthesized chemically. Biologics typically require cold-chain storage (refrigeration) and are distributed through specialty pharmacies rather than your local retail pharmacy. Many patients are surprised to learn their regular pharmacy doesn't carry Aimovig at all.
Even when your pharmacy can order it, the supply chain for specialty medications is more complex — involving specialty distributors, prior authorization, and sometimes direct shipment from the manufacturer. This creates more potential points of delay.
One of the biggest obstacles isn't supply — it's access. Most insurance plans require prior authorization before covering Aimovig, and many also require step therapy. That means you may need to try and fail other preventive medications (like Topiramate, Propranolol, or Amitriptyline) before your insurer will approve Aimovig.
Even after approval, some patients face denials, delays, and coverage gaps that make it feel like the medication is unavailable — when really, the barrier is administrative.
As of 2026, there is no generic or biosimilar version of Aimovig. That means Amgen is the sole manufacturer, and the medication is only available as the brand-name product. Without competition, there's less flexibility in the supply chain and no lower-cost alternative patients can pivot to if Aimovig is temporarily out of stock at their pharmacy.
While Aimovig isn't listed on the FDA Drug Shortage Database, patients have reported occasional difficulty filling prescriptions at certain pharmacies. These situations are usually distribution-related — meaning the medication exists, but it isn't where you need it to be at the right time. In 2023, some patients reported temporary supply disruptions that caused real concern, though these resolved without a formal shortage being declared.
Don't panic. There are concrete steps you can take to get your medication:
Rather than calling pharmacy after pharmacy, use Medfinder to quickly check which pharmacies near you have Aimovig in stock. It saves time and reduces the stress of the search.
If your local pharmacy doesn't carry Aimovig, ask your doctor's office about specialty pharmacy partners. Many insurance plans work with specific specialty pharmacies (like Accredo, CVS Specialty, or OptumRx) that keep Aimovig in stock and can ship it directly to your home.
Amgen's patient support program can help navigate insurance issues, connect you with the right pharmacy, and even provide free medication through their Safety Net Foundation if you qualify. Call 1-888-4AIMOVIG (1-888-424-6684) for assistance.
Since Aimovig is a once-monthly injection, planning ahead matters. Don't wait until you've used your last dose to request a refill. Try to reorder at least one to two weeks in advance to give the pharmacy and insurance system time to process everything.
If Aimovig is consistently difficult to access, your doctor may recommend switching to another CGRP inhibitor. Options like Ajovy (Fremanezumab), Emgality (Galcanezumab), Vyepti (Eptinezumab), or the oral option Qulipta (Atogepant) work through similar mechanisms and may be easier to fill at your pharmacy. Learn more about your options in our guide to alternatives to Aimovig.
Finding Aimovig shouldn't be harder than managing your migraines. The challenges are real — specialty pharmacy requirements, insurance hurdles, and distribution quirks all play a role — but they're also manageable.
Start by checking availability on Medfinder, lean on Amgen's support resources, and keep your prescriber in the loop. You've found a treatment that works — now it's about making sure you can keep getting it.
For more tips on tracking down your medication, read our guide on how to find Aimovig in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
